Nidan Laboratories And Healthcare
Nidan Laboratories And Healthcare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Nidan Laboratories And Healthcare
Start SIPNidan Laboratories And Healthcare Investment Rating
-
Master Rating:
-
Nidan Laboratories And Healthcare has an operating revenue of Rs. 93.24 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 15% is great, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Services and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2022 |
|---|---|
| Total Revenue Annual Cr | 30 |
| Operating Expenses Annual Cr | 20 |
| Operating Profit Annual in Cr | 9 |
| Depreciation Cr | 3 |
| Interest Annual Cr | 3 |
| Tax Annual Cr | 2 |
| Net Profit Annual Cr | 3 |
Nidan Laboratories And Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 12
- 20 Day
- ₹42.2
- 50 Day
- ₹42.52
- 100 Day
- ₹44.27
- 200 Day
- ₹46.37
- 20 Day
- ₹42.61
- 50 Day
- ₹41.17
- 100 Day
- ₹44.74
- 200 Day
- ₹48.45
Nidan Laboratories And Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹43.3 |
| Second Resistance | ₹44.1 |
| Third Resistance | ₹44.75 |
| RSI | 50.16 |
| MFI | 27.81 |
| MACD Single Line | 0.3 |
| MACD | 0.21 |
| Support | |
|---|---|
| First Resistance | ₹41.85 |
| Second Resistance | ₹41.2 |
| Third Resistance | ₹40.4 |
Nidan Laboratories And Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,000 | 300,000 | 100 |
| Week | 4,600 | 400,016 | 86.96 |
| 1 Month | 6,550 | 539,982 | 82.44 |
| 6 Month | 10,385 | 765,600 | 73.72 |
Nidan Laboratories And Healthcare Result Highlights
Nidan Laboratories And Healthcare Synopsis
NSE-Medical-Services
Nidan Laboratories is involved in the business activities of Other Hospital and Medical Care Activities. Company’s Total Operating Revenue is Rs. 29.66 Cr. and Equity Capital is Rs. 13.90 Cr. for the Year ended 31/03/2022. Nidan Laboratories And Healthcare Ltd. is a Public Limited Listed company incorporated on 05/12/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U33111MH2000PLC129883 and registration number is 129883.| Market Cap | 59 |
| Sales | 30 |
| Shares in Float | 0.40 |
| No of funds | |
| Yield |
| Book Value | 0.89 |
| U/D Vol ratio | 0.3 |
| LTDebt / Equity | 14 |
| Alpha | 0.14 |
| Beta | 0.87 |
Nidan Laboratories And Healthcare
| Owner Name | Mar-23 | Sep-22 |
|---|---|---|
| Promoters | 71.22% | 71.22% |
| Individual Investors | 26.62% | |
| Others | 2.16% | 28.78% |
Nidan Laboratories And Healthcare Management
| Name | Designation |
|---|---|
| Mr. Edwin Francis Dabre | Executive Director |
| Mrs. Tejal Anil Jayakar | Executive Director & CFO |
| Mr. Krupesh Deepak Thakur | Non Executive Director |
| Mr. Nilesh Ghanshyam Bide | Ind. Non-Executive Director |
| Mr. Abhinay Shashikant Nerurkar | Ind. Non-Executive Director |
| Mr. Karim Hakam Khimani | Ind. Non-Executive Director |
Nidan Laboratories And Healthcare Forecast
Price Estimates
Nidan Laboratories And Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-26 | Audited Results | |
| 2022-11-11 | Quarterly Results |
Nidan Laboratories And Healthcare FAQs
What is Share Price of Nidan Laboratories And Healthcare ?
Nidan Laboratories And Healthcare share price is ₹42 As on 28 May, 2023 | 11:05
What is the Market Cap of Nidan Laboratories And Healthcare ?
The Market Cap of Nidan Laboratories And Healthcare is ₹58.6 Cr As on 28 May, 2023 | 11:05
What is the P/E ratio of Nidan Laboratories And Healthcare ?
The P/E ratio of Nidan Laboratories And Healthcare is As on 28 May, 2023 | 11:05
What is the PB ratio of Nidan Laboratories And Healthcare ?
The PB ratio of Nidan Laboratories And Healthcare is 0.9 As on 28 May, 2023 | 11:05